Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: A review

European Psychiatry

Volumn 15, Issue 2, 2000, Pages 79-89

  Noble, E P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alcoholism; Dopamine; DRD2 gene; Drugs; Nicotine; Obesity

Indexed keywords

ALCOHOL; CARBON 11; DOPAMINE 2 RECEPTOR; FLUORODEOXYGLUCOSE F 18; IODINE 123; IODINE 125; NICOTINE; RACLOPRIDE; TRITIUM;

ADDICTION; ALCOHOLISM; ALLELE; BRAIN METABOLISM; CIGARETTE SMOKING; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; NEUROTOXICITY; OBESITY; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SCHIZOPHRENIA;

EID: 0034072399     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(00)00208-X     Document Type: Article

References (73)

1. Adams K.M., Gilman S., Koeppe R.A., Kluin K.J., Brunberg J.A., Dede D., et al. Neuropsychological deficits are correlated with frontal hypometabolism in positron emission tomography studies of older alcoholic patients. Alcohol Clin Exp Res. 17:1993;205-210.
2. Amadéo S., Abbar M., Fourcade M.L., Waksman G., Leroux M.G., Medec A., et al. D2 dopamine receptor gene and alcoholism. J Psychiatr Res. 27:1993;173-179.
3. Babor T.F., Hofmann M., DelBoca F.K., Hesselbrock V., Meyer R.E., Dolinsky Z.S., et al. Types of alcoholics: I. Evidence for an empirically derived typology based on indicators of vulnerability and severity. Arch Gen Psychiatry. 49:1992;599-608.
4. Benjamin J., Li L., Patterson C., Greenberg B.D., Murphy D.L., Hamer D.H. Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nat Genet. 12:1996;81-84.
5. Berman S.M., Noble E.P. Reduced visuospatial performance in children with the D2 dopamine receptor A1 allele. Behav Genet. 25:1995;45-58.
6. Berman S.M., Noble E.P. The D2 dopamine receptor (DRD2) gene and family stress. Interactive effects on cognitive functioning in children. Behav Genet. 27:1997;33-43.
7. Blum K., Braverman E.P., Dinardo M.J., Wood R.C., Sheridan P.J. Prolonged P300 latency in a neuropsychiatric population with the D2 dopamine receptor A1 allele. Pharmacogenetics. 3:1994;313-322.
8. Blum K., Noble E.P., Sheridan P.J., Finley O., Montgomery A., Ritchie T., et al. Association of the A1 allele of the human D2 dopamine receptor gene with severe alcoholism. Alcohol. 8:1991;409-416.
9. Blum K., Noble E.P., Sheridan P.J., Montgomery A., Ritchie T., Jagadeeswaran P., et al. Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA. 263:1990;2055-2060.
10. Blum K., Sheridan P.J., Wood R.C., Braverman E.R., Chen I.J.H., Comings D.E. Dopamine D2 receptor gene variants: Association and linkage studies in impulsive-addictive-compulsive behavior. Pharmacogenetics. 5:1995;121-141.
11. Bolos A.M., Dean M., Lucase-Derse S., Ramsburg M., Brown G.L., Goldman D., et al. Population and pedigree studies reveal a lack of association between the dopamine D2 receptor gene and alcoholism. JAMA. 264:1990;3156-3160.
12. Cloninger C.R. Neurogenetic adaptive mechanisms in alcoholism. Science. 236:1987;410-416.
13. Cloninger C.R. D2 dopamine receptor gene is associated but not linked with alcoholism. JAMA. 266:1991;1833-1834.
14. Comings D.E., Comings B.G., Muhleman D., Dietz G., Shahbahrami B., Tast D., et al. The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA. 266:1991;1793-1800.
15. Comings D.E., Ferry L., Bradshaw-Robinson S., Burchette R., Chiu C., Muhleman D. The dopamine D2 receptor (DRD2) gene: A genetic risk factor in smoking. Pharmacogenetics. 6:1996;73-79.
16. Comings D.E., Flanagan S.D., Dietz G., Muhleman D., Knell E., Gysin R. The dopamine D2 receptor (DRD2) as a major gene in obesity and height. Biochem Med Metab Biol. 50:1993;176-185.
17. Comings D.E., Gade R., Macmurray J.P., Muhleman D., Peters W.R. Genetic variants of the human obesity (OB) gene: association with body mass index in young women, psychiatric symptoms, and interaction with the dopamine D2 receptor (DRD2) gene. Mol Psychiatry. 1:1996;325-335.
18. Comings D.E., Muhleman D., Ahn C., Gysin R., Flanagan S.D. The dopamine D2 receptor gene: A genetic risk factor in substance abuse. Drug Alcohol Depend. 34:1994;175-180.
19. Cook B.L., Wang Z.W., Crowe R.R., Hauser R., Freimer M. Alcoholism and the D2 receptor gene. Alcohol Clin Exp Res. 16:1992;806-809.
20. Cook C.C.H., Gurling H.M.D. The D2 dopamine receptor gene and alcoholism: A genetic effect on the liability for alcoholism. J R Soc M. 87:1994;400-402.
21. Ebstein R.P., Novick O., Umansky R., Priel B., Osher Y., Blaine D., et al. Dopamine D4 receptor (DRD4) exon III polymorphism associated with the human personality trait of novelty seeking. Nat Genet. 12:1996;78-80.
22. Gabbay F.H., Duncan C.C., Bird G., Uhl G.R., Mirsky A.F. D2 dopamine receptor Taq1 A genotypic differences in event-related brain potentials. Harris L.S. Problems of Drug Dependence. NIDA Research Monograph 162. 129:1996;Rockville MD, NIH, National Institute of Drug Abuse.
23. Gehle V.M., Erwin V.G. Common quantitative trait loci for alcohol-related behaviors and CNS neurotensin measures: voluntary ethanol consumption. Alcohol Clin Exp Res. 22:1998;40-48.
24. Geijer T., Neiman J., Rydberg U., Gyllander A., Jöhnson E., Sedvall G., et al. Dopamine D2 receptor gene polymorphisms in Scandinavian chronic alcoholics. Eur Arch Psychiatry Clin Neursci. 244:1994;26-32.
25. Gelernter J., Goldman D., Risch N. The A1 allele of the D2 dopamine receptor gene and alcoholism. JAMA. 269:1993;1673-1677.
26. Gelernter J., O'Malley S., Risch N., Kranzler H.R., Krystal J., Merikangas K., et al. No association between an allele of the D2 dopamine receptor gene (DRD2) and alcoholism. JAMA. 266:1991;1801-1807.
27. Goldman D., Dean M., Brown G.L., Bolos A.N., Tokola R., Virkkunen M., et al. D2 dopamine receptor genotype and cerebral spinal fluid homovanillic acid, 5-hydroxyindoleacetic acid and 3-methoxy-4-hydroxyphenylglycol in alcoholics in Finland and the United States. Acta Psychiatr Scand. 86:1992;351-357.
28. Gorwood P., Ades J., Feingold J. Are genes coding for dopamine receptors implicated in alcoholism? Eur Psychiatry. 9:1994;63-69.
29. Grandy D.K., Litt M., Allen L., Bunzow J.R., Marchionni M., Makam H., et al. The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a Taq1 RFLP. Am J Hum Genet. 45:1989;778-785.
30. Heinz A., Sander T., Harms H., Finckh U., Kuhn S., Dufeu P., et al. Lack of allelic association of dopamine D1 and D2 (TaqI A) receptor gene polymorphisms with reduced dopaminergic sensitivity in alcoholism. Alcohol Clin Exp Res. 20:1996;1109-1113.
31. Hietala J., Pohjalainen T., Heikkila-Kallio U., West C., Salaspuro M., Syvälahti E. Allelic association between D2 but not D1 dopamine receptor gene and alcoholism in Finland. Psychiat Genet. 7:1997;19-25.
32. Hill S.Y., Locke J., Zezza N., Kaplan B., Neiswanger K., Steinhauer S.R., et al. Genetic association between reduced P300 amplitude and the DRD2 dopamine receptor A1 allele in children at high-risk for alcoholism. Biol Psychiatry. 43:1998;40-51.
33. Hitzemann R.J. The regulation of D2 dopamine receptor expression. Mol Psychiatry. 3:1998;198-203.
34. Jönsson E.G., Nöthen M.M., Gustavsson J.P., Neidt H., Brené S., Tylee A., et al. Lack of evidence for allelic association between personality traits and dopamine D4 receptor gene polymorphism. Am J Psychiatry. 154:1997;697-699.
35. Koob G.R. Drugs of abuse. Anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci. 13:1992;177-184.
36. Laruelle M., Gelernter J., Innis R.B. D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene. Mol Psychiatry. 3:1998;261-265.
37. Lawford B.R., Young R.M., Rowell J.A., Gibson J.N., Feeney G.F.X., Ritchie T.L., et al. Association of the D2 dopamine receptor A1 allele with alcoholism: Medical severity of alcoholism and type of controls. Biol Psychiatry. 41:1997;386-393.
38. Lawford B.R., Young R.M., Rowell J.A., Qualichefski J., Fletcher B.H., Syndulko K., et al. Bromocriptine in the treatment of alcoholics with the D2 dopamine receptor A1 allele. Nat M. 1:1995;337-341.
39. Maldonado R., Salardi A., Valverde O., Samad T.A., Roques B.P., Borrelli E. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature. 388:1997;586-589.
40. Malhotra A.K., Virkunnen M., Rooney W., Eggert M., Linnoila M., Goldman D. The association between the dopamine D4 receptor (DRD4) 16 amino acid repeat polymorphism and novelty seeking. Mol Psychiatry. 1:1996;388-391.
41. Neiswanger K., Hill S.Y., Kaplan B.B. Association and linkage studies of the TaqI A allele of the dopamine D2 receptor gene in samples of female and male alcoholics. Am J Med Genet. 60:1995;267-271.
42. Noble E.P. Alcoholism and the dopaminergic system: A review. Addict Biol. 1:1996;333-348.
43. Noble E.P. The D2 dopamine receptor gene: A review of association studies in alcoholism and phenotypes. Alcohol. 16:1998;33-45.
44. Noble E.P. The DRD2 gene, smoking, and lung cancer. J Natl Cancer Inst. 90:1998;343-345.
45. Noble E.P., Berman S.M., Ozkaragoz T.Z., Ritchie T. Prolonged P300 latency in children with the D2 dopamine receptor A1 allele. Am J Hum Genet. 54:1994;658-668.
46. Noble E.P., Blum K. Alcoholism and the D2 receptor gene [letter]. JAMA. 270:1993;1547.
47. Noble E.P., Blum K., Khalsa M.E., Ritchie T., Montgomery A., Wood R.D., et al. Allelic association of the D2 dopamine receptor gene with cocaine dependence. Drug Alcohol Depend. 33:1993;271-285.
48. Noble E.P., Blum K., Ritchie T., Montgomery A., Sheridan P.J. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry. 48:1991;648-654.
49. Noble E.P., Fitch R.J., Ritchie T., Brunner R.L., Zhang X., Stjeor S.C., et al. The D2 dopamine receptor gene: obesity, smoking and mood. St. Jeor S.T. Obesity Assessment. 1997;522-533 Chapman and Hall; New York.
50. Noble E.P., Gottschalk L.A., Fallon J.H., Ritchie T.L., Wu J.C. D2 dopamine receptor polymorphism and brain regional metabolism. Am J Med Genet. 74:1997;162-166.
51. Noble E.P., Lawford B.R., Ritchie T., Young R.M., Zhang X. The D2 dopamine receptor (DRD2) gene and methadone treatment outcome of opioid-dependent patients. Abstr Soc. Neurosci. 24:1998;770.
52. Noble E.P., Noble R.E., Ritchie T., Syndulko K., Bohlman M.C., Noble L.A., et al. D2 dopamine receptor gene and obesity. Int J Eating Disord. 15:1994;205-217.
53. Noble E.P., Ozkaragoz T.Z., Ritchie T., Zhang X., Belin T.R., Sparkes R.S. D2 and D4 dopamine receptor polymorphisms and personality. Am J Med Genet. 81:1998;257-267.
54. Noble E.P., Stjeor S.T., Ritchie T., Syndulko K., Stjeor S.C., Fitch R.J., et al. D2 dopamine receptor gene and cigarette smoking: A reward gene? Med Hypotheses. 42:1994;257-260.
55. Noble E.P., Syndulko K., Fitch R.J., Ritchie T., Bohlman M.C., Guth P., et al. TaqI A alleles in medically ill alcoholic and nonalcoholic patients. Alcohol Alcohol. 29:1994;729-744.
56. O'Hara B.F., Smith S.S., Bird G., Persico A.M., Suarez B.K., Cutting G.R., et al. Dopamine D2 receptor RFLPs, haplotypes and their association with substance use in black and Caucasian research volunteers. Hum Her. 43:1993;209-218.
57. Parsian A., Todd R.D., Devor E.J., O'Malley K.L., Suarez B.K., Reich T., et al. Alcoholism and alleles of the human D2 receptor locus: Studies of association and linkage. Arch Gen Psychiatry. 48:1991;655-663.
58. Pato C.N., Macciardi F., Pato M.T., Verga M., Kennedy H. Review of the putative association of dopamine D2 receptor and alcoholism: A meta-analysis. Am J Med Genet. 48:1993;78-82.
59. Persico A.M., Bird G., Gabbay F.H., Uhl G.R. D2 dopamine receptor gene TaqI A1 and B1 restriction fragment length polymorphism: Enhanced frequencies in psychostimulant-preferring polysubstance abusers. Biol Psychiatry. 40:1996;776-784.
60. Phillips T.J., Brown K.J., Burkhart-Kasch S., Wenger C.D., Kelly M.A., Rubinstein M., et al. Alcohol preference and sensitivity are markedly reduced in mice lacking dopamine D2 receptors. Nat Neurosci. 1:1998;610-615.
61. Phillips T.J., Crabbe J.C., Metten P., Belknap J.K. Localization of genes affecting alcohol drinking in mice. Alcohol Clin Exp Res. 18:1994;931-943.
62. Phillips T.J., Huson M., Gwazdon C., Burkhart-Kasch S., Shen E.H. Effects of acute and repeated ethanol exposures on the locomotor activity of RXD recombinant inbred mice. Alcohol Clin Exp Res. 19:1995;269-278.
63. Pohjalainen T., Rinne J.O., Någren K., Lehikoinen P., Anttila K., Syvälahti E.K.G., et al. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry. 3:1998;256-260.
64. Smith S.S., O'Hara B.F., Persico A.M., Gorelick D.A., Newlin D.B., Vlahov D., et al. Genetic vulnerability in drug abuse: The dopamine D2 receptor TaqI B RFLP is more frequent in polysubstance abusers. Arch Gen Psychiatry. 49:1992;723-727.
65. Spitz M.R., Shi H., Yang F., Hudmon K.S., Jiang H., Chamberlain R.M., et al. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst. 90:1998;358-363.
66. Suarez B.K., Parsian A., Hampe C.L., Todd R.D., Reich T., Cloninger C.R. Linkage disequilibria and the D2 dopamine receptor locus (DRD2) in alcoholics and controls. Genomics. 19:1994;12-20.
67. Tarantino L.M., McClearn G.E., Rodriguez L.A., Plomin R. Confirmation of quantitative trait loci for alcohol preference in mice. Alcohol Clin Exp Res. 22:1998;1099-1105.
68. Thompson J., Thomas N., Singleton A., Piggott M., Lloyd S., Perry C.M., et al. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics. 7:1997;479-484.
69. Uhl G., Blum K., Noble E., Smith S. Substance abuse vulnerability and D2 receptor gene. Trends Neurosci. 16:1993;83-88.
70. Volkow N.D., Fowler J.B., Wang G.J., Hitzemann R., Logan J., Schyler D.J., et al. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse. 14:1993;169-177.
71. Volkow N.D., Hitzemann R., Wang G.J., Fowler J.S., Wolf A.P., Dewey S.L., et al. Long-term frontal brain metabolism changes in cocaine abusers. Synapse. 11:1992;184-190.
72. Wik G., Borg S., Sjögren I., Wiesel F.A., Bloomquist G., Borg J., et al. PET determination of regional cerebral glucose metabolism in alcohol-dependent men and healthy controls using 11C-glucose. Acta Psychiatr Scand. 78:1988;234-241.
73. Wise R.A., Rompre P.P. Brain dopamine and reward. Annu Rev Psychol. 40:1989;191-225.